Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter medical ab* - vítamín a (palmítat); colecalciferolum inn; vítamín e (tocoferolum nfn); acidum ascorbicum inn; thiaminum cocarboxylase tetrahýdrat; riboflavinum natríumfosfat díhýdrat; pyridoxinum hýdróklóríð; cyanocobalaminum inn; acidum folicum inn; dexpanthenolum inn; biotinum inn; nicotinamidum inn - stungulyfsstofn, lausn

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

fresenius kabi ab - natrii ascorbas inn; thiaminum nítrat; natrii riboflavinophosphas; natrii pantothenas; pyridoxinum hýdróklóríð; biotinum inn; cyanocobalaminum inn; acidum folicum inn; nicotinamidum inn - innrennslisstofn, lausn

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

merck ab - levothyroxinum natríum - tafla - 100 míkróg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

merck ab - levothyroxinum natríum - tafla - 50 míkróg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

merck ab - levothyroxinum natríum - tafla - 25 míkróg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

orifarm healthcare a/s - levothyroxinum natríum - tafla - 0,05 mg

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

orifarm healthcare a/s - levothyroxinum natríum - tafla - 0,1 mg

Den Europæiske Union - islandsk - EMA (European Medicines Agency)

biogen idec ltd - daclizumab - margvísleg sclerosis - Ónæmisbælandi lyf - zinbryta er ætlað fullorðnum sjúklingum til að meðhöndla endurteknar gerðir af mænusigg (rms).

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

baxter holding b.v.* - sodium hydrogen carbonate; sodium chloride; calcium chloride; magnesii chloridum; acidum lacticum - blóðskilunar-/blóðsíunarlausn

Island - islandsk - LYFJASTOFNUN (Icelandic Medicines Agency)

santen oy* - tafluprostum inn - augndropar, lausn - 15 míkróg/ml